Panacea Biotec (BOM:531349) Marketable Securities : ₹0 Mil (As of Dec. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Panacea Biotec Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Panacea Biotec's Marketable Securities for the quarter that ended in Dec. 2024 was ₹0 Mil.

Panacea Biotec's annual Marketable Securities declined from Mar. 2022 (₹5,013 Mil) to Mar. 2023 (₹1,732 Mil) and declined from Mar. 2023 (₹1,732 Mil) to Mar. 2024 (₹1,091 Mil).

Panacea Biotec Marketable Securities Historical Data

The historical data trend for Panacea Biotec's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Panacea Biotec Marketable Securities Chart

Panacea Biotec Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Marketable Securities

Get a 7-Day Free Trial

149.88

433.65

5,012.78

1,731.97

1,091.19

Panacea Biotec Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Marketable Securities	Get a 7-Day Free Trial															-	1,091.19	-	1,547.70	-

Panacea Biotec Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Panacea Biotec (BOM:531349) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Panacea Biotec Marketable Securities Related Terms

Thank you for viewing the detailed overview of Panacea Biotec's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Panacea Biotec Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Panacea Biotec Ltd (BOM:531349) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

PANACEABIO:India

Address

Mathura Road, B-1 Extension/G-3, Mohan Co-operative Industrial Estate, New Delhi, IND, 110 044

Website

https://www.panaceabiotec.com

Panacea Biotec Ltd is a Biotechnology company. It is engaged in the business of research, development, manufacturing, and marketing of branded pharmaceutical formulations, vaccines, and biopharmaceuticals. The company's operating segments include Vaccines, and Formulations. It generates maximum revenue from the Vaccines segment. The company product portfolio includes prescription products in niche therapeutic areas such as diabetes and cardiovascular management, oncology, nephrology and transplant management, osteoporosis management, gastro-intestinal care, pain management products, and pediatric immunization. The group has a business presence in India and Outside India.

Panacea Biotec Headlines

No Headlines